Carmustine Kit
Product Images NDC 71288-126

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Carmustine (NDC 71288-126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Car0x 0001 01)

Chemical structure of Carmustine showing its molecular formula with chlorine, nitrogen, carbon, oxygen, and hydrogen atoms arranged in specific bonds.*

FDA Label Image

Figure (Car0x 0001 02)

Carmustine for Injection, USP 100 mg per vial kit held in a hand. The label indicates the dosage form as a kit for intravenous use, containing carmustine for injection. The package shows the product name, strength, route, and labeler Meitheal Pharmaceuticals Inc. clearly on the vial and accompanying packaging insert.*

FDA Label Image

Figure (Car0x 0001 03)

Carmustine kit for intravenous injection by Meitheal Pharmaceuticals Inc. It includes a vial labeled Carmustine 100 mg per vial for injection and a separate vial of 3 ml diluent. The kit is intended for reconstitution prior to administration.*

FDA Label Image

Figure (Car0x 0001 04)

The image shows a kit for Carmustine injectable solution, 100 mg per vial, labeled for intravenous use. The vial is accompanied by a diluent vial labeled for product use. The kit is held by a gloved hand, demonstrating preparation for injection, which includes a syringe extracting the solution. The labeler displayed is Meitheal Pharmaceuticals Inc.*

FDA Label Image

Figure (Car0x 0001 05)

An instructional image labeled STEP 4 shows a syringe extracting liquid from a vial labeled Carmustine for Injection, USP 100 mg per vial. The vial is brown with a white label and green highlight. Beside it is a smaller clear vial labeled Dextrose Injection USP 5%, 3 mL, identified as the diluent vial of the product kit. Both vials are held in a white plastic stand.*

FDA Label Image

Figure (Car0x 0001 06)

Carmustine 100 mg per vial injection kit for intravenous use by Meitheal Pharmaceuticals Inc. The kit contains a brown glass vial labeled Carmustine Injection, USP 100 mg per vial, and a smaller vial of diluent labeled Injection Alcohol USP 3 mL. The vials are housed in a white plastic holder with red text indicating 'Product Kit of Product & Diluent.' The label includes dosage and administration details.*

FDA Label Image

Figure (Car0x 0001 07)

An instructional image labeled Step 6, showing a gloved hand using a syringe to draw liquid from a vial labeled Carmustine Injection, USP 100 mg per 10 mL. Next to it, a kit holder contains a smaller vial labeled as a product diluent, with text indicating "Product Kit," "Product," and "Diluent." This image demonstrates part of the preparation process for the Carmustine intravenous injection kit from Meitheal Pharmaceuticals Inc.*

FDA Label Image

Figure (Car0x 0001 08)

Carmustine for Injection, USP 100 mg vial in a kit with a 3 mL vial of sterile water for injection labeled as product diluent. The vials are held in a white plastic frame labeled 'Product Kit of Product & Diluent'. The kit is intended for intravenous use, labeled by Meitheal Pharmaceuticals Inc.*

FDA Label Image

Figure (Car0x 0001 09)

An instructional image showing step 8 in the preparation of Carmustine for intravenous use. A gloved hand holds a white plastic kit containing two vials: a small vial on the left and a larger vial on the right labeled 'Carmustine for intravenous use.' A syringe is drawing liquid from the larger vial, demonstrating a step in medication preparation.*

FDA Label Image

Vial Label (Car0x 0001 10 V2)

Label for Carmustine for Injection, USP 100 mg per vial, a single-dose vial for intravenous infusion after reconstitution. The label instructs immediate refrigeration and disposal of unused portions. It includes storage and handling details, precautions, and is labeled for prescription use only. The label is from Meitheal Pharmaceuticals Inc.*

FDA Label Image

Diluent Label (Car0x 0001 11 V2)

Packaging label for Dehydrated Alcohol Injection, USP, 3 mL sterile diluent for Carmustine for Injection, USP. The label includes storage instructions to keep the product refrigerated (2°C to 8°C, 36°F to 46°F) and notes that the closure is not made with natural rubber latex. The labeler is Meitheal Pharmaceuticals Inc.*

FDA Label Image

Carton (Car0x 0001 12 V2)

Packaging label for Carmustine for Injection, USP 100 mg per vial kit by Meitheal Pharmaceuticals Inc. The label includes storage instructions to refrigerate immediately, and indicates the product is for intravenous infusion after reconstitution, single-dose vial. It also contains warnings, dosage preparation instructions, and manufacturer details with barcode and NDC 71288-126-90.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.